SCHEMBL6277145

SCHEMBL6277145

Cc1oc(-c2ccccc2)nc1CCOc1ccc(CC(C)(N)C(=O)O)cc1

nearest known ligand 0.75

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 20/20 0.75
PPARG P37231 15/20 0.75
PPARD Q03181 8/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6277149 1.00 PPARA (0.75) PPARAPPARGPPARD
SCHEMBL7903440 0.90 PPARA (0.78) PPARAPPARGPPARD
SCHEMBL6383130 0.90 PPARA (0.78) PPARAPPARGPPARD
SCHEMBL7905565 0.88 PPARA (0.73) PPARAPPARGPPARD
SCHEMBL6382177 0.87 PPARA (0.74) PPARAPPARGPPARD
SCHEMBL5113930 0.86 PPARA (1.00) PPARAPPARGPPARD
SCHEMBL5110800 0.86 PPARA (1.00) PPARAPPARGPPARD
SCHEMBL5207260 0.86 PPARA (1.00) PPARAPPARGPPARD
SCHEMBL5113061 0.86 PPARA (1.00) PPARAPPARGPPARD
SCHEMBL5207274 0.86 PPARA (1.00) PPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6933309-B2 Halogenobenzyl aminopropionic acid derivatives TOAEIYO LTD. (JP) 2005-08-23 US disclosed
US-20040102439-A1 Halogenobenzyl aminopropionic acid derivatives TOAEIYO LTD. (JP) 2004-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102439-A1 Halogenobenzyl aminopropionic acid derivatives FABP4, SLC5A1, ALDH7A1 PPARA 24/4885PPARG 34/4885PPARD 74/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.